Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice.
cannabinoid receptor (CB1R)
endocannabinoids
leptin
obesity
orexin
reward
Journal
Frontiers in synaptic neuroscience
ISSN: 1663-3563
Titre abrégé: Front Synaptic Neurosci
Pays: Switzerland
ID NLM: 101548972
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
10
2020
accepted:
11
01
2021
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese
Identifiants
pubmed: 33613258
doi: 10.3389/fnsyn.2021.622405
pmc: PMC7890184
doi:
Types de publication
Journal Article
Langues
eng
Pagination
622405Informations de copyright
Copyright © 2021 Tunisi, D'Angelo, Fernández-Rilo, Forte, Piscitelli, Imperatore, de Girolamo, Di Marzo and Cristino.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Comp Neurol. 2003 Oct 27;465(4):593-603
pubmed: 12975818
Nature. 2005 Sep 22;437(7058):556-9
pubmed: 16100511
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):132-142
pubmed: 28259721
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
pubmed: 22908200
Brain Res Brain Res Rev. 1993 Jan-Apr;18(1):75-113
pubmed: 8096779
Br J Pharmacol. 2015 Jan;172(2):334-48
pubmed: 24641197
Cell Metab. 2013 Apr 2;17(4):475-90
pubmed: 23562074
Mol Metab. 2017 Apr 22;6(6):594-601
pubmed: 28580289
Neuroscience. 2008 Oct 28;156(4):865-71
pubmed: 18790017
Neuropsychopharmacology. 2016 Jul;41(8):2101-11
pubmed: 26787120
Nat Neurosci. 2005 Nov;8(11):1442-4
pubmed: 16251985
CNS Drugs. 2016 May;30(5):369-79
pubmed: 27155860
Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):261-268
pubmed: 28364268
Front Endocrinol (Lausanne). 2019 Dec 10;10:830
pubmed: 31920958
J Neurosci. 2015 May 6;35(18):7295-303
pubmed: 25948277
Expert Opin Ther Targets. 2002 Oct;6(5):601-9
pubmed: 12387683
Pharmacol Res. 2016 Sep;111:600-609
pubmed: 27436148
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10720-E10729
pubmed: 30348772
Neuropharmacology. 2008 Jan;54(1):95-107
pubmed: 17655884
J Physiol. 2020 Dec;598(23):5523-5539
pubmed: 32886798
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19168-73
pubmed: 16357203
Eur J Nutr. 2016 Jun;55(4):1799-805
pubmed: 26759262
Psychopharmacology (Berl). 2014 Jan;231(2):419-27
pubmed: 23978908
Psychopharmacology (Berl). 2011 Mar;214(2):415-26
pubmed: 20959967
Cell Metab. 2009 Aug;10(2):89-98
pubmed: 19656487
J Neurosci. 2006 Jan 11;26(2):398-405
pubmed: 16407535
Arch Biochem Biophys. 2011 Apr 1;508(1):1-12
pubmed: 21176768
J Neurosci. 1984 Nov;4(11):2877-90
pubmed: 6150071
PLoS One. 2014 Jan 23;9(1):e87478
pubmed: 24466352
Trends Neurosci. 2000 Aug;23(8):359-65
pubmed: 10906799
Vitam Horm. 2012;89:185-208
pubmed: 22640614
Addict Biol. 2015 May;20(3):469-81
pubmed: 24712379
Neuroscience. 2010 Apr 28;167(1):11-20
pubmed: 20149847
Eur J Neurosci. 2008 Oct;28(8):1629-40
pubmed: 18973582
J Comp Neurol. 2001 Jun 18;435(1):6-25
pubmed: 11370008
J Mol Neurosci. 2011 Feb;43(2):217-24
pubmed: 21086064
Behav Brain Res. 2014 Oct 1;272:93-9
pubmed: 24983661
Sleep Med Rev. 2000 Feb;4(1):57-99
pubmed: 12531161
Nutr Rev. 2015 May;73(5):296-307
pubmed: 26011903
Neuron. 2006 Sep 21;51(6):811-22
pubmed: 16982425
PLoS One. 2010 Jul 09;5(7):e11503
pubmed: 20634890
Exp Neurobiol. 2018 Aug;27(4):309-319
pubmed: 30181693
J Neurosci. 2011 Oct 12;31(41):14600-10
pubmed: 21994376
Addict Biol. 2017 Nov;22(6):1695-1705
pubmed: 27480648
Psychopharmacology (Berl). 2018 Oct;235(10):3031-3043
pubmed: 30109373
Front Behav Neurosci. 2012 Nov 28;6:82
pubmed: 23226119
J Neurosci. 2004 Jan 7;24(1):53-62
pubmed: 14715937
Neuropsychopharmacology. 2016 Jan;41(2):508-20
pubmed: 26081302
Neuron. 2006 Feb 16;49(4):589-601
pubmed: 16476667
Brain Res. 1999 Mar 13;821(2):526-9
pubmed: 10064841
Neuropsychopharmacology. 2018 Jan;43(1):103-115
pubmed: 28653666
Neuroscience. 2002;111(2):379-87
pubmed: 11983323
Neuropsychopharmacology. 2012 Aug;37(9):1999-2011
pubmed: 22569505
Front Behav Neurosci. 2015 Dec 17;9:336
pubmed: 26733830
Cell Rep. 2017 Feb 7;18(6):1346-1355
pubmed: 28178514
Nat Commun. 2016 Jul 22;7:12199
pubmed: 27448020
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4759-64
pubmed: 27071101
Nat Neurosci. 2010 May;13(5):635-41
pubmed: 20348917
Cell. 2015 Jan 29;160(3):528-41
pubmed: 25635460
Peptides. 2005 Nov;26(11):2331-8
pubmed: 15893404
Brain Res. 2000 Aug 4;873(1):181-7
pubmed: 10915829
Neuroscience. 2012 May 17;210:243-8
pubmed: 22433299
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2229-38
pubmed: 23630288
Prog Neurobiol. 2002 Nov;68(4):247-86
pubmed: 12498988
Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R592-9
pubmed: 27385732